1-12273
|
51-0263969
|
(COMMISSION FILE NUMBER)
|
(IRS EMPLOYER IDENTIFICATION NO.)
|
6901 PROFESSIONAL PKWY. EAST, SUITE 200, SARASOTA, FLORIDA
|
34240
|
|
|
(ADDRESS OF PRINCIPAL EXECUTIVE OFFICES)
|
(ZIP CODE)
|
Not applicable. |
Not applicable. |
Not applicable |
99.1 Press Release of the Company dated April 26, 2011. |
Roper Industries, Inc. | |||||||
(Registrant) | |||||||
BY: | /s/ John Humphrey | ||||||
John Humphrey, Vice President and Chief Financial Officer |
Date: April 26, 2011 |
Exhibit No. | Description | |
|
|
|
99.1 | Press Release of the Company dated April 26, 2011 |
Contact Information:
Investor Relations
941-556-2601
investor-relations@roperind.com
|
Roper Industries, Inc.
|
Q1 2011
|
|
Total Sales Growth
|
21%
|
Acquisitions / Divestitures
|
4%
|
Foreign Currency
|
1%
|
Organic
|
16%
|
Q1 2011
|
Q1 2010
|
|||
Net Earnings
|
$89.0
|
$59.7
|
||
Add: Interest Expense
|
16.7
|
16.2
|
||
Add: Income Taxes
|
37.0
|
25.3
|
||
Add: Depreciation & Amortization
|
34.3
|
28.5
|
||
EBITDA (A)
|
$177.0
|
$129.7
|
||
Revenue (B)
|
$645.3
|
$534.4
|
||
EBITDA Margin (A)/(B)
|
27.4%
|
24.3%
|
March 31,
|
December 31,
|
||
ASSETS
|
2011
|
2010
|
|
CURRENT ASSETS:
|
|||
Cash and cash equivalents
|
$ 261,447
|
$ 270,394
|
|
Accounts receivable
|
413,371
|
403,337
|
|
Inventories
|
198,788
|
178,559
|
|
Unbilled receivable
|
79,072
|
75,620
|
|
Deferred taxes
|
33,834
|
32,894
|
|
Other current assets
|
43,128
|
37,287
|
|
Total current assets
|
1,029,640
|
998,091
|
|
PROPERTY, PLANT AND EQUIPMENT, NET
|
103,639
|
103,487
|
|
|
|||
OTHER ASSETS:
|
|||
Goodwill
|
2,748,510
|
2,727,780
|
|
Other intangible assets, net
|
1,083,482
|
1,104,513
|
|
Deferred taxes
|
55,629
|
57,850
|
|
Other assets
|
75,994
|
77,803
|
|
Total other assets
|
3,963,615
|
3,967,946
|
|
TOTAL ASSETS
|
$ 5,096,894
|
$ 5,069,524
|
|
LIABILITIES AND STOCKHOLDERS' EQUITY
|
|||
CURRENT LIABILITIES:
|
|||
Accounts payable
|
$ 147,015
|
$ 137,778
|
|
Accrued liabilities
|
268,036
|
298,080
|
|
Income taxes payable
|
-
|
-
|
|
Deferred taxes
|
10,664
|
10,445
|
|
Current portion of long-term debt
|
81,826
|
93,342
|
|
Total current liabilities
|
507,541
|
539,645
|
|
NONCURRENT LIABILITIES:
|
|||
Long-term debt
|
1,159,961
|
1,247,703
|
|
Deferred taxes
|
474,185
|
465,001
|
|
Other liabilities
|
73,078
|
66,268
|
|
Total liabilities
|
2,214,765
|
2,318,617
|
|
STOCKHOLDERS' EQUITY:
|
|||
Common stock
|
977
|
971
|
|
Additional paid-in capital
|
1,060,785
|
1,045,286
|
|
Retained earnings
|
1,759,282
|
1,680,849
|
|
Accumulated other comprehensive earnings
|
81,188
|
43,978
|
|
Treasury stock
|
(20,103)
|
(20,177)
|
|
Total stockholders' equity
|
2,882,129
|
2,750,907
|
|
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY
|
$ 5,096,894
|
$ 5,069,524
|
Three months ended
|
|||
March 31,
|
|||
2011
|
2010
|
||
Net sales
|
$ 645,309
|
$ 534,441
|
|
Cost of sales
|
295,213
|
254,876
|
|
Gross profit
|
350,096
|
279,565
|
|
Selling, general and administrative expenses
|
208,096
|
178,849
|
|
Income from operations
|
142,000
|
100,716
|
|
Interest expense
|
16,696
|
16,181
|
|
Other income
|
711
|
447
|
|
Earnings from continuing operations before
|
|||
income taxes
|
126,015
|
84,982
|
|
Income taxes
|
37,036
|
25,257
|
|
Net Earnings
|
$ 88,979
|
$ 59,725
|
|
Earnings per share:
|
|||
Basic
|
$ 0.93
|
$ 0.64
|
|
Diluted
|
$ 0.91
|
$ 0.62
|
|
Weighted average common and common
|
|||
equivalent shares outstanding:
|
|||
Basic
|
95,374
|
93,810
|
|
Diluted
|
98,153
|
96,036
|
Three months ended March 31,
|
||||||||
2011
|
2010
|
|||||||
Amount
|
%
|
Amount
|
%
|
|||||
Net sales:
|
||||||||
Industrial Technology
|
$ 169,982
|
$ 135,312
|
||||||
Energy Systems & Controls
|
129,633
|
105,678
|
||||||
Medical & Scientific Imaging
|
145,287
|
130,244
|
||||||
RF Technology
|
200,407
|
163,207
|
||||||
Total
|
$ 645,309
|
$ 534,441
|
||||||
Gross profit:
|
||||||||
Industrial Technology
|
$ 85,714
|
50.4%
|
$ 67,512
|
49.9%
|
||||
Energy Systems & Controls
|
70,146
|
54.1%
|
53,491
|
50.6%
|
||||
Medical & Scientific Imaging
|
91,254
|
62.8%
|
77,510
|
59.5%
|
||||
RF Technology
|
102,982
|
51.4%
|
81,052
|
49.7%
|
||||
Total
|
$ 350,096
|
54.3%
|
$ 279,565
|
52.3%
|
||||
Operating profit*:
|
||||||||
Industrial Technology
|
$ 46,189
|
27.2%
|
$ 31,766
|
23.5%
|
||||
Energy Systems & Controls
|
29,044
|
22.4%
|
18,923
|
17.9%
|
||||
Medical & Scientific Imaging
|
35,037
|
24.1%
|
29,334
|
22.5%
|
||||
RF Technology
|
44,950
|
22.4%
|
32,201
|
19.7%
|
||||
Total
|
$ 155,220
|
24.1%
|
$ 112,224
|
21.0%
|
||||
Net Orders:
|
||||||||
Industrial Technology
|
$ 200,742
|
$ 154,093
|
||||||
Energy Systems & Controls
|
134,205
|
115,300
|
||||||
Medical & Scientific Imaging
|
150,265
|
131,110
|
||||||
RF Technology
|
217,087
|
166,743
|
||||||
Total
|
$ 702,299
|
$ 567,246
|
Three months ended
|
||||
March 31,
|
||||
2011
|
2010
|
|||
Net earnings
|
$ 88,979
|
$ 59,725
|
||
Non-cash items:
|
||||
Depreciation
|
9,256
|
9,409
|
||
Amortization
|
25,054
|
19,095
|
||
Stock-based compensation expense
|
8,112
|
7,008
|
||
Income taxes
|
3,424
|
11,353
|
||
Changes in assets and liabilities:
|
||||
Receivables
|
(18,181)
|
2,781
|
||
Inventory
|
(16,359)
|
(2,344)
|
||
Accounts payable
|
6,854
|
12,901
|
||
Accrued liabilities
|
(23,466)
|
(24,762)
|
||
Other, net
|
2,911
|
(80)
|
||
Cash provided by operating activities
|
86,584
|
95,086
|
||
Business acquisitions, net of cash acquired
|
-
|
(15,000)
|
||
Capital expenditures
|
(8,813)
|
(6,485)
|
||
Other, net
|
(198)
|
2,841
|
||
Cash used by investing activities
|
(9,011)
|
(18,644)
|
||
Principal debt borrowings
|
-
|
-
|
||
Principal debt payments
|
(11,968)
|
(2,999)
|
||
Revolver borrowings (payments), net
|
(85,000)
|
(40,000)
|
||
Debt issuance costs
|
-
|
-
|
||
Dividends
|
(10,458)
|
(8,878)
|
||
Excess tax benefit from share-based payment
|
2,855
|
1,021
|
||
Proceeds from exercise of stock options
|
8,607
|
2,443
|
||
Other, net
|
(118)
|
366
|
||
Cash used by financing activities
|
(96,082)
|
(48,047)
|
||
Effect of exchange rate changes on cash
|
9,562
|
(4,818)
|
||
Net increase (decrease) in cash and equivalents
|
(8,947)
|
23,577
|
||
Cash and equivalents, beginning of period
|
270,394
|
167,708
|
||
Cash and equivalents, end of period
|
$261,447
|
$191,285
|